acquired
Stage
2
Investors
About
Dark Blue Therapeutics is a biotechnology company specializing in precision oncology, leveraging academic partnerships to develop targeted therapies for cancer by exploiting novel vulnerabilities and dependencies in cancer cells.
Explore Dark Blue Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.